Patent 11116205 was granted and assigned to Biomatrica on September, 2021 by the United States Patent and Trademark Office.
The present invention relates to reduction of erythrocyte sedimentation rate in a blood sample. In particular, formulations, compositions, articles of manufacture, kits and methods for reduced erythrocyte sedimentation rate in a blood sample are provided.